Zobrazeno 1 - 10
of 3 637
pro vyhledávání: '"Brekke, J."'
Autor:
Lorea Odriozola Larrañaga
Publikováno v:
Comunitania. Revista Internacional de Trabajo Social y Ciencias Sociales. :111-113
Autor:
Schaufel MA; Lungeavdelingen, Haukeland universitetssjukehus, og, Institutt for klinisk medisin, Universitetet i Bergen., Gärtner F; Lungeavdelingen, Haukeland universitetssjukehus., Leivdal BK; Lungeavdelingen, Haukeland universitetssjukehus., Haug SA; Palliativt senter, Haukeland universitetssjukehus., Brekke J; Avdeling for kreftbehandling og medisinsk fysikk, Haukeland universitetssjukehus., Storstein AM; Nevrologisk avdeling, Haukeland universitetssjukehus., Tveiten ØV; Nevrokirurgisk avdeling, Haukeland universitetssjukehus., Bødtker JE; Avdeling for psykosomatisk medisin, Psykiatrisk klinikk, Haukeland universitetssjukehus., Fløtten Ø; Lungeavdelingen, Haukeland universitetssjukehus, og, Institutt for klinisk medisin, Universitetet i Bergen.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2024 Jul 18; Vol. 144 (9). Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Autor:
Gebrehiwet P; Health Economics and Outcomes Research, Cytokinetics, Incorporated ,South San Francisco, CA, USA., Brekke J; Medical Affairs, Cytokinetics, Incorporated, South San Francisco, CA, USA., Rudnicki SA; Clinical Research, Cytokinetics, Incorporated, South San Francisco, CA, USA and., Mellor J; Real World Evidence, Adelphi Real World, Bollington, UK., Wright J; Real World Evidence, Adelphi Real World, Bollington, UK., Earl L; Real World Evidence, Adelphi Real World, Bollington, UK., Ball N; Real World Evidence, Adelphi Real World, Bollington, UK., Iqbal H; Real World Evidence, Adelphi Real World, Bollington, UK., Thomas O; Real World Evidence, Adelphi Real World, Bollington, UK., Castellano G; Real World Evidence, Adelphi Real World, Bollington, UK.
Publikováno v:
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2024 May; Vol. 25 (3-4), pp. 345-357. Date of Electronic Publication: 2023 Dec 29.
Autor:
Svalastoga, M., Larsen, T., Brekke, J., Enden, T., Frøen, H., Garresori, H., Jacobsen, E., Porojnicu, A., Ree, A., Torfoss, D., Velle, E., Skuterud Wik, H., Ghanima, W., Sandset, P., Dahm, A.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Autor:
Brekke, J, Balke Staver, A
The growing use of data gathered from social media in asylum claim assessments raises critical yet underexplored ethical questions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::b7c27f74b7be78b983df6950e0e838f3
https://ora.ox.ac.uk/objects/uuid:e4956577-7b04-49b5-a901-53cb555c842d
https://ora.ox.ac.uk/objects/uuid:e4956577-7b04-49b5-a901-53cb555c842d
Autor:
Larsen TL; Faculty of Medicine, University of Oslo, Postboks 1078, Blindern, 0316 Oslo, Norway; Department of Hematology, Akershus University Hospital, P.O. BOX 1000, N-1478 Lørenskog, Norway. Electronic address: tlhannevik@gmail.com., Svalastoga M; Faculty of Medicine, University of Oslo, Postboks 1078, Blindern, 0316 Oslo, Norway. Electronic address: marte.svalastoga@studmed.uio.no., Brekke J; Department of Oncology, Haukeland University Hospital, P.O. BOX 1400, N-5021 Bergen, Norway. Electronic address: jorunn.brekke@helse-bergen.no., Enden T; Tidsskriftet, den norske legeforening, Postboks 1152, Sentrum, 0107 Oslo, Norway. Electronic address: tone.enden@online.no., Frøen H; Department of Haematology, Oslo University Hospital, P.O. BOX 4950, Nydalen, N-0424 Oslo, Norway., Garresori H; Department of Oncology, Stavanger University Hospital, P.O. BOX 8100, N-4068 Stavanger, Norway. Electronic address: herish.garresori@sus.no., Jacobsen EM; Department of Haematology, Oslo University Hospital, P.O. BOX 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: evamj@broadpark.no., Paulsen PQ; Department of Hematology, St. Olav's University Hospital, P.O. BOX 3250, Torgarden, N-7006 Trondheim, Norway. Electronic address: Petter.Quist.Paulsen@stolav.no., Porojnicu AC; Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, P.O. BOX 800, N-3004 Drammen, Norway. Electronic address: alinacp@vestreviken.no., Ree AH; Faculty of Medicine, University of Oslo, Postboks 1078, Blindern, 0316 Oslo, Norway; Department of Oncology, Akershus University Hospital, P.O. BOX 1000, N-1478 Lørenskog, Norway. Electronic address: a.h.ree@medisin.uio.no., Torfoss D; Department of Oncology, Oslo University Hospital, P.O. BOX 4950 Nydalen, N-0424 Oslo, Norway., Velle EO; Department of Medicine, Volda Hospital, Møre and Romsdal Hospital, P.O. BOX b 113, 6101 Volda, Norway. Electronic address: elin.velle@tussa.com., Wik HS; Department of Haematology, Oslo University Hospital, P.O. BOX 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: hilde.skuterud.wik@vikenfiber.no., Ghanima W; Faculty of Medicine, University of Oslo, Postboks 1078, Blindern, 0316 Oslo, Norway; Clinic of Internal Medicine, Østfold Hospital, P.O. BOX 300, N-1714 Grålum, Norway. Electronic address: Waleed.Ghanima@so-hf.no., Sandset PM; Faculty of Medicine, University of Oslo, Postboks 1078, Blindern, 0316 Oslo, Norway; Department of Haematology, Oslo University Hospital, P.O. BOX 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: p.m.sandset@admin.uio.no., Dahm AEA; Faculty of Medicine, University of Oslo, Postboks 1078, Blindern, 0316 Oslo, Norway; Department of Hematology, Akershus University Hospital, P.O. BOX 1000, N-1478 Lørenskog, Norway.
Publikováno v:
Thrombosis research [Thromb Res] 2023 Aug; Vol. 228, pp. 128-133. Date of Electronic Publication: 2023 May 25.
Autor:
Larsen TL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Hematology, Akershus University Hospital, Lørenskog, Norway., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Brekke J; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Enden T; Department of Radiology, Oslo University Hospital, Oslo, Norway., Frøen H; Department of Medicine, Baerum Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Jacobsen EM; Department of Hematology, Oslo University Hospital, Oslo, Norway., Quist-Paulsen P; Department of Hematology, St. Olav's University Hospital, Trondheim, Norway., Porojnicu AC; Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Ree AH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Torfoss D; Department of Oncology, Oslo University Hospital, Oslo, Norway., Velle EO; Department of Medicine, Volda Hospital, Møre and Romsdal Hospital Trust Volda, Ålesund, Norway., Wik HS; Department of Hematology, Oslo University Hospital, Oslo, Norway., Ghanima W; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Clinic of Internal Medicine, Østfold Hospital, Grålum, Norway., Sandset PM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway., Dahm AEA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Hematology, Akershus University Hospital, Lørenskog, Norway.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Aug; Vol. 20 (8), pp. 1937-1939.
Autor:
Heggebø LC; Department of Oncology, Oslo University Hospital, Oslo, Norway licahe@ous-hf.no.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Borgen IMH; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, Norway., Rylander H; Skandion Clinic, Uppsala, Sweden., Kiserud C; Department of Oncology, Oslo University Hospital, Oslo, Norway., Nordenmark TH; Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Oslo, Norway.; Department of Psychology, Faculty of Social Sciences, University of Oslo, Oslo, Norway., Hellebust TP; Department of Medical Physics, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Evensen ME; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Section of Oncology, Drammen Hospital, Drammen, Norway., Gustavsson M; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Medical Radiation Science, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden., Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway., Sprauten M; Department of Oncology, Oslo University Hospital, Oslo, Norway., Magelssen H; Department of Oncology, Oslo University Hospital, Oslo, Norway., Blakstad H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Moorthy J; Department of Oncology, Oslo University Hospital, Oslo, Norway., Andersson K; Skandion Clinic, Uppsala, Sweden., Raunert I; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden., Henry T; Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Medical Radiation Science, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden., Moe C; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Granlund C; Department of Oncology, Oslo University Hospital, Oslo, Norway., Goplen D; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Brekke J; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Johannessen TA; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Solheim TS; Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Marienhagen K; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Humberset Ø; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Bergström P; Department of Oncology, University Hospital of Umeå, Umeå, Sweden., Agrup M; Department of Oncology, Linköping University Hospital, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Dahl L; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Gubanski M; Department of Radiotherapy, Karolinska University Hospital, Stockholm, Sweden., Gojon H; Department of Radiotherapy, Karolinska University Hospital, Stockholm, Sweden., Brahme CJ; Skandion Clinic, Uppsala, Sweden., Rydén I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Jakola AS; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden.; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden., Vik-Mo EO; Department of Neurosurgery, Oslo University Hospital, Oslo, Norway., Lie HC; Department of Behavioural Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Asphaug L; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Hervani M; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kristensen I; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Rueegg CS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Olsen IC; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Ledal RJ; Norwegian Brain Tumor Alliance, Oslo, Norway., Degsell E; Swedish Brain Tumor Association, Stockholm, Sweden., Werlenius K; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Blomstrand M; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Oncology, Institute of Clinical Sciences, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden., Brandal P; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
Publikováno v:
BMJ open [BMJ Open] 2023 Mar 20; Vol. 13 (3), pp. e070071. Date of Electronic Publication: 2023 Mar 20.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.